We are live on ! Find out more
USNA icon

Usana Health Sciences

165 hedge funds and large institutions have $371M invested in Usana Health Sciences in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 65 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

10.89% more ownership

Funds ownership: 59.13%70.02% (+11%)

10% more capital invested

Capital invested by funds: $336M → $371M (+$35.2M)

7% more call options, than puts

Call options by funds: $531K | Put options by funds: $498K

1% more funds holding

Funds holding: 164165 (+1)

20% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 65

Holders
165
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
2.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
24
Increased
52
Reduced
65
Closed
21
Calls
$531K
Puts
$498K
Net Calls
+$33K
Net Calls Change
-$214K
Name Holding Trade Value Shares
Change
Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
$106K +$40.8K +1,327 +53%
New York State Common Retirement Fund
102
New York State Common Retirement Fund
New York
$105K -$114K -3,700 -49%
PFSRSONJ
103
Police & Firemen's Retirement System of New Jersey
New Jersey
$95.4K +$32.3K +1,051 +44%
Comerica Bank
104
Comerica Bank
Texas
$93.8K -$23.2K -753 -18%
Fidelity Investments
105
Fidelity Investments
Massachusetts
$87.9K -$5.05K -164 -5%
AB
106
Amalgamated Bank
New York
$86K +$985 +32 +1%
TRSOTSOK
107
Teachers Retirement System of the State of Kentucky
Kentucky
$85K -$27.8K -902 -23%
BNP Paribas Financial Markets
108
BNP Paribas Financial Markets
France
$78.5K -$197K -6,394 -69%
Osaic Holdings
109
Osaic Holdings
Arizona
$70.4K -$985 -32 -1%
Royal Bank of Canada
110
Royal Bank of Canada
Ontario, Canada
$70K -$264K -8,572 -77%
OPERF
111
Oregon Public Employees Retirement Fund
Oregon
$67.5K
NAAA
112
New Age Alpha Advisors
New York
$62.6K
A
113
AlphaQuest
New York
$53.7K -$221K -7,197 -79%
National Bank of Canada
114
National Bank of Canada
Quebec, Canada
$53K +$37K +1,201 +167%
AAP
115
Arax Advisory Partners
Colorado
$49.9K +$54.9K +1,783 +6,368%
SAM
116
Shell Asset Management
Netherlands
$37K -$66.9K -2,175 -62%
CPG
117
Cornerstone Planning Group
New Jersey
$36K +$12.1K +394 +5,629%
Simplex Trading
118
Simplex Trading
Illinois
$35K +$39.2K +1,274 New
AIP
119
Ameritas Investment Partners
Nebraska
$30.9K
US Bancorp
120
US Bancorp
Minnesota
$23.1K -$147K -4,762 -85%
S
121
SignatureFD
Georgia
$22.9K -$369 -12 -1%
GI
122
GAMMA Investing
California
$21.4K +$1.78K +58 +8%
SCM
123
Sterling Capital Management
North Carolina
$20.9K +$13.9K +453 +148%
TRCT
124
Tower Research Capital (TRC)
New York
$18K -$53.7K -1,745 -73%
EP
125
Essential Partners
California
$17.8K +$19.9K +646 New

USNA Hedge Fund Activity: Q3 2025 in Review

165 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2025, worth a combined $371M — up 10% from $336M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 21 closed out — a net gain of 3 holders — while 52 added to existing stakes and 65 trimmed.

The largest buyer was Summit Wealth Group (Colorado), opening a new position worth an estimated $51.1M. The largest seller was Citadel Advisors, cutting an estimated $3.52M.

  • 165 institutional investors held Usana Health Sciences (USNA) as of Q3 2025, up from 164 in Q2 2025.
  • Funds reported $371M of Usana Health Sciences stock for Q3 2025, up 10% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q3 2025 and 21 closed out, a net change of +3 holders.
  • The largest Usana Health Sciences buyer in Q3 2025 was Summit Wealth Group (Colorado), an estimated $51.1M added.
  • The largest Usana Health Sciences seller in Q3 2025 was Citadel Advisors, an estimated $3.52M sold.

Based on aggregated 13F filings for Q3 2025.